The U.S. Food and Drug Administration has given the injectable Xolair (omalizumab) the green light for use in decreasing the risk of life-threatening reactions to certain foods. Doctors weighed in.
Comments
FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods
FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods